RMIT University
Browse

Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial

journal contribution
posted on 2024-11-02, 21:34 authored by Lu Liu, Shui Qing ZhangShui Qing Zhang, Hui-Lin Liu, Fan He
Objective: The aim of this study was to evaluate the efficacy of acupuncture, an alternative medicine therapy, as a preventive treatment for menstruation-related migraine (MRM). Patients and methods: This was a prospective, multicenter, double-dummy, participant-blinded, randomized controlled clinical trial conducted in China between 1 April 2013, and 30 April 2014. The participants were enrolled from four study centers and randomized to into either the acupuncture group, which received 24 sessions of acupuncture at traditional acupoints plus placebo, or the medication group, which received sham acupuncture plus naproxen. The primary endpoint was change from the baseline average number of migraine days per perimenstrual period over cycles 1−3. The secondary endpoints included changes from the baseline average number of migraine days outside the perimenstrual period, mean number of migraine hours during and outside the perimenstrual period, mean visual analog scale score during and outside the perimenstrual period, ≥50% migraine responder rate, and the proportion of participants who used acute pain medication over cycles 1−3 and 4−6. Results: A total of 172 women with MRM were enrolled; 170 in the intention-to-treat analyses. Our primary outcome reported a significant between-group difference that favored the acupuncture group (95% CI, 0.17–0.50; P < 0.001), with the average reduction of migraine days per perimenstrual period from the baseline was 0.94 (95% CI, 0.82–1.07) in the acupuncture group and 0.61 (95% CI, 0.50–0.71) in the medication group over cycles 1−3. Conclusion: This study showed that compared to medication, acupuncture reduces the number of migraine days experienced by patients with MRM. For patients who received the acupuncture treatment over three cycles, the preventive effect of the therapy was sustained for six cycles. Clinical trial registration: [https://www.isrctn.com/ISRCTN57133712], identifier [ISRCTN15663606].

History

Related Materials

  1. 1.
    DOI - Is published in 10.3389/fnins.2022.992577
  2. 2.
    ISSN - Is published in 16624548

Journal

Frontiers in Neuroscience

Volume

16

Number

992577

Start page

1

End page

14

Total pages

14

Publisher

Frontiers

Place published

Switzerland

Language

English

Copyright

© 2022 Liu, Zhang, Liu, He, Lyu, Zeng, Zhao, Wang, Qu, Nie, Guo, Zhang, Lu, Wang, Li, Jing and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License (CC BY).

Former Identifier

2006118599

Esploro creation date

2023-04-28

Usage metrics

    Scholarly Works

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC